Resuscitation of hypotensive patients with sepsis traditionally involves up to several litres of crystalloid fluids before vasopressors are initiated.  While this forms the basis for many sepsis management guidelines, the dogma is being challenged.

In this latest podcast from the 2021 ANZICS CTG meeting in Noosa, Stephen McDonald joins Todd to talk about the ARISE FLUIDS 2 trial, which aims to provide more detail on the prioritisation of these two key interventions.

Baxter Healthcare has provided an educational grant to sponsor the following podcast. The content was developed independently of Baxter Healthcare and opinions expressed are those of the presenting healthcare professional.